Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patients

Virus Research

Volumn 130, Issue 1-2, 2007, Pages 285-291

  López Labrador, F Xavier ^a,b   Dove, Lorna ^c   Hui, Chee Kin ^d   Phung, Yume ^d   Kim, Michael ^d   Berenguer, Marina ^e,f   Wright, Teresa L ^d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

AIDS; CD4 counts; Coinfection; Envelope; Immune pressure; NS3

Indexed keywords

NONSTRUCTURAL PROTEIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

ADULT; CD4 LYMPHOCYTE COUNT; CLUSTER ANALYSIS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VARIATION (GENETICS); VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35748947247     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.05.016     Document Type: Article

References (18)

1. Babik J.M., and Holodniy M. Impact of highly active antiretroviral therapy and immunologic status on Hepatitis C Virus quasispecies diversity in human immunodeficiency virus/Hepatitis C Virus-coinfected patients. J. Virol. 77 3 (2003) 1940-1950
2. Blackard J.T., Yang Y., Bordoni P., Sherman K.E., and Chung R.T. Hepatitis C Virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. J. Infect. Dis. 189 8 (2004) 1472-1481 Epub 2004, Mar 29
3. Chazouilleres O., Kim M., Combs C., Ferrell L., Bacchetti P., Roberts J., Ascher N.L., Neuwald P., Wilber J., Urdea M., et al. Quantitation of Hepatitis C Virus RNA in liver transplant recipients. Gastroenterology 106 4 (1994) 994-999
4. Devereux H., Brown D., Dusheiko G., Emery V., and Lee C. Long-term evolution of the 5′UTR and a region of NS4 containing a CTL epitope of Hepatitis C Virus in two haemophilic patients. J. Gen. Virol. 78 3 (1997) 583-590
5. Ducoulombier D., Roque-Afonso A.M., Di Liberto G., Penin F., Kara R., Richard Y., Dussaix E., and Feray C. Frequent compartmentalization of Hepatitis C Virus variants in circulating B cells and monocytes. Hepatology 39 3 (2004) 817-825
6. Kimura M. The Neutral Theory of Molecular Evolution (1983), Cambridge University Press, Cambridge
7. Kumar S., Tamura K., Jakobsen I.B., and Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17 12 (2001) 1244-1245
8. López-Labrador F.X., He X.S., Berenguer M., Cheung R.C., Gonzalez-Candelas F., Wright T.L., and Greenberg H.B. Genetic variability of Hepatitis C Virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C. J. Med. Virol. 72 4 (2004) 575-585
9. Mao Q., Ray S.C., Laeyendecker O., Ticehurst J.R., Strathdee S.A., Vlahov D., and Thomas D.L. Human immunodeficiency virus seroconversion and evolution of the Hepatitis C Virus quasispecies. J. Virol. 75 7 (2001) 3259-3267
10. Martinot-Peignoux M., Boyer N., Le Breton V., Le Guludec G., Castelnau C., Akremi R., and Marcellin P. A new step toward standardization of serum Hepatitis C Virus-RNA quantification in patients with chronic hepatitis C. Hepatology 31 3 (2000) 726-729
11. Nei M., and Kumar S. Molecular Evolution and Phylogenetics (2000), Oxford University Press, New York
12. Qin H., Shire N.J., Keenan E.D., Rouster S.D., Eyster M.E., Goedert J.J., Koziel M.J., Sherman K.E., and Multicenter Hemophilia Cohort Study Group. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 105 2 (2005) 533-541
13. Roque-Afonso A.M., Ducoulombier D., Di Liberto G., Kara R., Gigou M., Dussaix E., Samuel D., and Feray C. Compartmentalization of Hepatitis C Virus genotypes between plasma and peripheral blood mononuclear cells. J. Virol. 79 10 (2005) 6349-6357
14. Sherman K.E., Andreatta C., O'Brien J., Gutierrez A., and Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 23 4 (1996) 688-694
15. Shuhart M.C., Sullivan D.G., Bekele K., Harrington R.D., Kitahata M.M., Mathisen T.L., Thomassen L.V., Emerson S.S., and Gretch D.R. HIV infection and antiretroviral therapy: effect on Hepatitis C Virus quasispecies variability. J. Infect. Dis. 193 9 (2006) 1211-1218
16. Thomas D.L. Hepatitis C and human immunodeficiency virus infection. Hepatology 36 5 Suppl. 1 (2002) S201-S209
17. Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.L., Houghton M., et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180 2 (1991) 842-848
18. Wolinsky S.M., Korber B.T., Neumann A.U., Daniels M., Kunstman K.J., Whetsell A.J., Furtado M.R., Cao Y., Ho D.D., and Safrit J.T. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272 5261 (1996) 537-542